---
title: "IMMP.US (IMMP.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IMMP.US/news.md"
symbol: "IMMP.US"
name: "IMMP.US"
parent: "https://longbridge.com/en/quote/IMMP.US.md"
datetime: "2026-03-14T15:26:09.308Z"
locales:
  - [en](https://longbridge.com/en/quote/IMMP.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IMMP.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IMMP.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/IMMP.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/IMMP.US/news.md)


# IMMP.US (IMMP.US) — Related News

### [Immutep Stock Tanks After Futility Analysis Ends Key Lung Cancer Trial Early](https://longbridge.com/en/news/279077899.md)
*2026-03-13T17:23:00.000Z*
> Immutep Limited has announced the discontinuation of its TACTI-004 Phase 3 trial due to a futility analysis, leading to 

### [Dr. Reddy’s Flags Phase III Setback as Immutep Halts Key Lung Cancer Trial](https://longbridge.com/en/news/279076056.md)
*2026-03-13T17:18:54.000Z*
> Dr. Reddy’s Flags Phase III Setback as Immutep Halts Key Lung Cancer Trial

### [US GDP Growth Revised Downward To 0.7% In Q4, Fed's Favorite Inflation Gauge Ticks Higher](https://longbridge.com/en/news/279049670.md)
*2026-03-13T12:36:00.000Z*
> U.S. GDP growth for Q4 2025 was revised down to 0.7%, significantly lower than the initial 1.4% estimate, reflecting wea

### [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://longbridge.com/en/news/279042114.md)
*2026-03-13T12:05:46.000Z*
> In Friday's pre-market session, health care stocks showed significant movement. Specimen (ISPC) surged 105.3% to $0.46, 

### [This EverCommerce Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday](https://longbridge.com/en/news/279038933.md)
*2026-03-13T11:40:59.000Z*
> Wall Street analysts have downgraded several companies, including EverCommerce Inc (EVCM), which was downgraded from Mar

### [Immutep halts late-stage trial for lead asset after efficacy analysis](https://longbridge.com/en/news/279032924.md)
*2026-03-13T11:12:30.000Z*
> Immutep halts late-stage trial for lead asset after efficacy analysis

### [Immutep Discontinues Phase III Trial Of Eftilagimod Alfa In First-Line NSCLC; Stock Drops](https://longbridge.com/en/news/279000682.md)
*2026-03-13T07:34:04.000Z*
> Immutep Limited (IMM.AX, IMMP) has announced the discontinuation of its Phase III TACTI-004 trial for eftilagimod alfa i

### [Immutep crashes 90% as Phase III lung cancer trial discontinued](https://longbridge.com/en/news/278986601.md)
*2026-03-13T05:08:23.000Z*
> Immutep's TACTI-004 Phase III lung cancer trial has been discontinued after an interim futility analysis, causing shares